Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Liabilities and Shareholders Equity (2016 - 2026)

InflaRx's Liabilities and Shareholders Equity history spans 10 years, with the latest figure at $57.2 million for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 37.45% to $57.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $280.8 million, a 22.09% decrease, with the full-year FY2025 number at $64.3 million, down 20.88% from a year prior.
  • Liabilities and Shareholders Equity hit $57.2 million in Q1 2026 for InflaRx, down from $64.3 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for IFRX hit a ceiling of $144.8 million in Q2 2023 and a floor of $57.2 million in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $102.0 million across 5 years, with a median of $100.2 million in 2024.
  • Biggest five-year swings in Liabilities and Shareholders Equity: grew 25.81% in 2023 and later plummeted 37.91% in 2024.
  • Tracing IFRX's Liabilities and Shareholders Equity over 5 years: stood at $104.5 million in 2022, then rose by 23.8% to $129.3 million in 2023, then plummeted by 37.19% to $81.2 million in 2024, then fell by 20.88% to $64.3 million in 2025, then dropped by 10.95% to $57.2 million in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for IFRX at $57.2 million in Q1 2026, $64.3 million in Q4 2025, and $76.2 million in Q3 2025.